ABSTRACT
There are three requirements for successful immunotherapy of a malignant tumor, whether a transplanted tumor in an experimental animal or a spontaneous cancer in a human patient: (1) Immunogenic tumor, (2) intact cell-mediated immunity, and (3) low tumor burden.
